resveratrol has been researched along with Nociceptive Pain in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Han, Y; Jamangulova, N; Jiang, C; Liu, W; Song, X; Tang, J; Wang, C; Wu, P; Wu, X; Zhang, G | 1 |
| Kamata, H; Karibe, H; Oshima, K; Sekiguchi, K; Shibuya, E; Shimazu, Y; Takeda, M; Takehana, S | 1 |
| Chen, J; Chen, L; Cheng, R; Ma, Q; Pan, X; Wang, G; Wang, L; Wang, W; Wu, H; Zhang, J; Zhang, M | 1 |
3 other study(ies) available for resveratrol and Nociceptive Pain
| Article | Year |
|---|---|
Resveratrol reduces morphine tolerance by inhibiting microglial activation via AMPK signalling.
Topics: Aminoimidazole Carboxamide; AMP-Activated Protein Kinases; Analgesics, Opioid; Animals; Anti-Inflammatory Agents, Non-Steroidal; Behavior, Animal; Cell Line; Drug Tolerance; Interleukin-1beta; Interleukin-6; Mice; Microglia; Morphine; NF-kappa B; Nitric Oxide Synthase Type II; Nociceptive Pain; p38 Mitogen-Activated Protein Kinases; Resveratrol; Ribonucleotides; Signal Transduction; Stilbenes; Toll-Like Receptor 4; Tumor Necrosis Factor-alpha | 2014 |
Local administration of resveratrol inhibits excitability of nociceptive wide-dynamic range neurons in rat trigeminal spinal nucleus caudalis.
Topics: Action Potentials; Analysis of Variance; Anesthetics, Local; Animals; Anti-Inflammatory Agents, Non-Steroidal; Dose-Response Relationship, Drug; Injections, Subcutaneous; Lidocaine; Male; Nociception; Nociceptive Pain; Nociceptors; Physical Stimulation; Rats; Rats, Wistar; Resveratrol; Stilbenes; Trigeminal Nucleus, Spinal | 2016 |
Resveratrol-induced antinociception is involved in calcium channels and calcium/caffeine-sensitive pools.
Topics: Analgesics; Animals; Behavior, Animal; Brain-Derived Neurotrophic Factor; Caffeine; Calcium Channel Blockers; Calcium Channels; Calcium Chelating Agents; Calcium Chloride; Calcium Signaling; Calcium-Calmodulin-Dependent Protein Kinase Type 2; Disease Models, Animal; Dose-Response Relationship, Drug; Egtazic Acid; Male; Mice, Inbred ICR; Nociception; Nociceptive Pain; Phosphorylation; Reaction Time; Resveratrol; Ryanodine; Spinal Cord; Stilbenes; Time Factors | 2017 |